- Category
- Micro (2020-21)
- Udyam number
- UDYAM-DL-10-0002184

Dr Horton Pharmaceuticals Private Limited
About Dr Horton Pharmaceuticals Private Limited
Data last updated:
Dr Horton Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the medical appliances and instruments segment of the healthcare sector. It was incorporated on 21 August 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U33119DL2020PTC368337.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Usha Rani and Kanchan Kumari Meena.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Rz – 8H/10 Gali No. 5/10 Main Sagar Pur Nangal Raya South West Delhi, Delhi, India – 110046.
As per the financials filed for FY 2025, the company reported a revenue of ₹26.23 Lakh, a decline of 39% compared to the previous year. For the same year it recorded a net loss of ₹12,272 (net margin -0.5%) and EBITDA of -₹2,968 (EBITDA margin -0.1%). Revenue has grown at a compounded annual rate (CAGR) of 17% over three years.
Court records list 1 case involving the company, including 1 filed against it.
Dr Horton Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-10-0002184).
Company details
Recognitions & Rankings of Dr Horton Pharmaceuticals
Contact details
Dr Horton Pharmaceuticals Private Limited's registered office is in Delhi, Delhi.
- Registered AddressRz – 8H/10 Gali No. 5/10 Main Sagar Pur Nangal Raya South West Delhi, Delhi, India – 110046
- IndustryHealthcare, Medical Appliances And Instruments, Manufacturing, Medical & Surgical Equipment, Orthopedic Appliances, Other Medical And Surgical Equipment
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Dr Horton Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Dr Horton Pharmaceuticals Private Limited, buy the company report.
Financials of Dr Horton Pharmaceuticals Private Limited
FY 2025 filings availableDr Horton Pharmaceuticals Private Limited reported revenue of ₹26.23 Lakh (down 39% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 39% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 17%. EBITDA rose 73% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹2,968 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹12,272 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -0.1% | ||||
| Net Profit Margin | -0.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Dr Horton Pharmaceuticals Private Limited, buy the company report.
Board of directors of Dr Horton Pharmaceuticals Private Limited
Dr Horton Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Usha Rani Also directs: Dr Horton Overseas Private Limited | Director | 21 Aug 2020 | 6 Years 2 Months | Current |
| Kanchan Kumari Meena | Director | 07 Sep 2024 | 2 Years 2 Months | Current |
Legal cases
Dr Horton Pharmaceuticals Private Limited has 1 court case on record: 1 filed against it. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, East, Delhi | Court case (Civ Suit) | Filed against the company by JJJ and Company LLP Thru Abhishek Jain Ar | Disposed |
To see the full case history of Dr Horton Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Dr Horton Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Dr Horton Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Dr Horton Pharmaceuticals Private Limited has 3 board changes on record since 2020: 2 appointments and 1 cessation. The latest: Gaurav Chauhan ceased to be Director on 07 Sep 2024.
Frequently asked questions
Dr Horton Pharmaceuticals is an active private limited company based in Delhi, India. The company works in medical appliances and instruments, within the healthcare industry. It was incorporated on 21 August 2020 (6+ years old) and is registered under CIN U33119DL2020PTC368337.
Dr Horton Pharmaceuticals has 2 current directors:
- Usha Rani - Director
- Kanchan Kumari Meena - Director
The latest financial statements of Dr Horton Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of Dr Horton Pharmaceuticals is U33119DL2020PTC368337. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dr Horton Pharmaceuticals has 1 court case on record: 1 filed against it.
Dr Horton Pharmaceuticals was incorporated on 21 August 2020, making it 6+ years old. It is registered with the Registrar of Companies, Delhi.
Gaurav Chauhan ceased to be Director on 07 Sep 2024. Kanchan Kumari Meena was appointed as Director on 07 Sep 2024. Usha Rani was appointed as Director on 21 Aug 2020.
Yes, Dr Horton Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-10-0002184).
The registered office of Dr Horton Pharmaceuticals is at Rz – 8H10 Gali No. 510 Main Sagar Pur Nangal Raya South West Delhi, Delhi, India – 110046.
Dr Horton Pharmaceuticals operates in the healthcare industry, in the medical appliances and instruments segment.

